The influence of serotonin transporter polymorphisms on cortical activity: A resting EEG study

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Lee, Tien Wen ^a,b   Yu, Younger W Y ^c   Hong, Chen Jee ^d,e   Tsai, Shih Jen ^d,e   Wu, Hung Chi ^f   Chen, Tai Jui ^g,h  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Yu's Psychiatric Clinic   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

^g E DA HOSPITAL   (Taiwan)

^h I SHOU UNIVERSITY   (Taiwan)

Author keywords

5 HTTLPR5 HTTVNTR; Electroencephalography (EEG)power spectrum; Polymorphism

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; BRAIN CORTEX; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; STEADY STATE; VARIABLE NUMBER OF TANDEM REPEAT; ELECTROENCEPHALOGRAPHY; GENETICS; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; YOUNG ADULT;

EID: 79954617058     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-33     Document Type: Article

References (90)

1. Hoehe MR, Wendel B, Grunewald I, Chiaroni P, Levy N, Morris-Rosendahl D, Macher JP, Sander T, Crocq MA. Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders. Am J Med Genet 1998, 81:1-3. 10.1002/(SICI)1096-8628(19980207)81:1<1::AID-AJMG1>3.0.CO;2-2, 9514579.
2. Kuzelova H, Ptacek R, Macek M. The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature. Neuro Endocrinol Lett 2010, 31:4-10.
3. Gorwood P, Batel P, Ades J, Hamon M, Boni C. Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 2000, 48:259-264. 10.1016/S0006-3223(00)00840-4, 10960156.
4. Ramasubbu R, Tobias R, Bech-Hansen NT. Extended evaluation of serotonin transporter gene functional polymorphisms in subjects with post-stroke depression. Can J Psychiatry 2008, 53:197-201.
5. Barton DA, Esler MD, Dawood T, Lambert EA, Haikerwal D, Brenchley C, Socratous F, Hastings J, Guo L, Wiesner G, et al. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry 2008, 65:38-46. 10.1001/archgenpsychiatry.2007.11, 18180427.
6. Lau JY, Goldman D, Buzas B, Fromm SJ, Guyer AE, Hodgkinson C, Monk CS, Nelson EE, Shen PH, Pine DS, Ernst M. Amygdala function and 5-HTT gene variants in adolescent anxiety and major depressive disorder. Biol Psychiatry 2009, 65:349-355. 10.1016/j.biopsych.2008.08.037, 2791528, 18950748.
7. You JS, Hu SY, Chen B, Zhang HG. Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatr Genet 2005, 15:7-11. 10.1097/00041444-200503000-00002, 15722951.
8. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996, 347:731-733. 10.1016/S0140-6736(96)90079-3, 8602004.
9. Nellissery M, Feinn RS, Covault J, Gelernter J, Anton RF, Pettinati H, Moak D, Mueller T, Kranzler HR. Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics. Alcohol Clin Exp Res 2003, 27:1402-1408. 10.1097/01.ALC.0000085588.11073.BB, 14506400.
10. Ohara K, Suzuki Y, Ochiai M, Tsukamoto T, Tani K, Ohara K. A variable-number-tandem-repeat of the serotonin transporter gene and anxiety disorders. Prog Neuropsychopharmacol Biol Psychiatry 1999, 23:55-65. 10.1016/S0278-5846(98)00091-8, 10368856.
11. Tsai SJ, Ouyang WC, Hong CJ. Association for serotonin transporter gene variable number tandem repeat polymorphism and schizophrenic disorders. Neuropsychobiology 2002, 45:131-133. 10.1159/000054952, 11979062.
12. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274:1527-1531. 10.1126/science.274.5292.1527, 8929413.
13. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, et al. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 2000, 23:587-590. 10.1016/S0893-133X(00)00132-9, 11027924.
14. Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 2007, 64:783-792. 10.1001/archpsyc.64.7.783, 17606812.
15. Murphy GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 2004, 61:1163-1169. 10.1001/archpsyc.61.11.1163, 15520364.
16. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996, 66:2621-2624.
17. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005, 29:8-16. 10.1097/01.ALC.0000150008.68473.62, 15654286.
18. Dannlowski U, Ohrmann P, Bauer J, Deckert J, Hohoff C, Kugel H, Arolt V, Heindel W, Kersting A, Baune BT, Suslow T. 5-HTTLPR biases amygdala activity in response to masked facial expressions in major depression. Neuropsychopharmacology 2008, 33:418-424. 10.1038/sj.npp.1301411, 17406646.
19. Dannlowski U, Konrad C, Kugel H, Zwitserlood P, Domschke K, Schoning S, Ohrmann P, Bauer J, Pyka M, Hohoff C, et al. Emotion specific modulation of automatic amygdala responses by 5-HTTLPR genotype. Neuroimage 2009,
20. Rao H, Gillihan SJ, Wang J, Korczykowski M, Sankoorikal GM, Kaercher KA, Brodkin ES, Detre JA, Farah MJ. Genetic variation in serotonin transporter alters resting brain function in healthy individuals. Biol Psychiatry 2007, 62:600-606. 10.1016/j.biopsych.2006.11.028, 17481593.
21. Graff-Guerrero A, De la Fuente-Sandoval C, Camarena B, Gomez-Martin D, Apiquian R, Fresan A, Aguilar A, Mendez-Nunez JC, Escalona-Huerta C, Drucker-Colin R, Nicolini H. Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism. Neuroimage 2005, 25:1197-1204. 10.1016/j.neuroimage.2004.12.020, 15850737.
22. Bertolino A, Arciero G, Rubino V, Latorre V, De Candia M, Mazzola V, Blasi G, Caforio G, Hariri A, Kolachana B, et al. Variation of human amygdala response during threatening stimuli as a function of 5'HTTLPR genotype and personality style. Biol Psychiatry 2005, 57:1517-1525. 10.1016/j.biopsych.2005.02.031, 15953488.
23. Tsai SJ, Hong CJ, Cheng CY. Serotonin transporter genetic polymorphisms and harm avoidance in the Chinese. Psychiatr Genet 2002, 12:165-168. 10.1097/00041444-200209000-00008, 12218661.
24. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism?. Hum Mol Genet 1997, 6:2233-2238. 10.1093/hmg/6.13.2233, 9361027.
25. Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH. 5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism. Am J Psychiatry 2006, 163:2148-2156. 10.1176/appi.ajp.163.12.2148, 17151167.
26. Hranilovic D, Stefulj J, Furac I, Kubat M, Balija M, Jernej B. Serotonin transporter gene promoter (5-HTTLPR) and intron 2 (VNTR) polymorphisms in Croatian suicide victims. Biol Psychiatry 2003, 54:884-889. 10.1016/S0006-3223(03)00179-3, 14573315.
27. Frei E, Gamma A, Pascual-Marqui R, Lehmann D, Hell D, Vollenweider FX. Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA). Hum Brain Mapp 2001, 14:152-165. 10.1002/hbm.1049, 11559960.
28. Saletu B, Grunberger J, Anderer P, Linzmayer L, Zyhlarz G. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry. J Neural Transm 1996, 103:191-216. 10.1007/BF01292627, 9026373.
29. Knott VJ, Howson AL, Perugini M, Ravindran AV, Young SN. The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects. Biol Psychiatry 1999, 46:229-238. 10.1016/S0006-3223(98)00338-2, 10418698.
30. Schenk GK, Filler W, Ranft W, Zerbin D. Double-blind comparisons of a selective serotonin reuptake inhibitor, zimelidine, and placebo on quantified EEG parameters and psychological variables. Acta Psychiatr Scand Suppl 1981, 290:303-313.
31. Siepmann M, Grossmann J, Muck-Weymann M, Kirch W. Effects of sertraline on autonomic and cognitive functions in healthy volunteers. Psychopharmacology (Berl) 2003, 168:293-298.
32. Siepmann T, Mueck-Weymann M, Oertel R, Kirch W, Pittrow D, Siepmann M. The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers. Pharmacopsychiatry 2008, 41:146-150. 10.1055/s-2008-1076724, 18651343.
33. Ahveninen J, Jaaskelainen IP, Pennanen S, Liesivuori J, Ilmoniemi RJ, Kahkonen S. Auditory selective attention modulated by tryptophan depletion in humans. Neurosci Lett 2003, 340:181-184. 10.1016/S0304-3940(03)00102-2, 12672536.
34. Kahkonen S, Jaaskelainen IP, Pennanen S, Liesivuori J, Ahveninen J. Acute tryptophan depletion decreases intensity dependence of auditory evoked magnetic N1/P2 dipole source activity. Psychopharmacology (Berl) 2002, 164:221-227.
35. Ahveninen J, Kahkonen S, Pennanen S, Liesivuori J, Ilmoniemi RJ, Jaaskelainen IP. Tryptophan depletion effects on EEG and MEG responses suggest serotonergic modulation of auditory involuntary attention in humans. Neuroimage 2002, 16:1052-1061. 10.1006/nimg.2002.1142, 12202092.
36. Young AH, Hughes JH, Marsh VR, Ashton CH. Acute tryptophan depletion attenuates auditory event related potentials in bipolar disorder: a preliminary study. J Affect Disord 2002, 69:83-92. 10.1016/S0165-0327(00)00382-7, 12103455.
37. Kahkonen S, Ahveninen J, Jaaskelainen IP, Pennanen S, Liesivuori J, Nikulin VV. Acute tryptophan depletion does not change somatosensory evoked magnetic fields. Psychopharmacology (Berl) 2003, 170:332-333.
38. McAllister-Williams RH, Massey AE, Rugg MD. Effects of tryptophan depletion on brain potential correlates of episodic memory retrieval. Psychopharmacology (Berl) 2002, 160:434-442.
39. Hughes JH, Ashton CH, Matthews D, Young AH. Acute depletion of plasma tryptophan does not alter electrophysiological variables in healthy males. Psychopharmacology (Berl) 2000, 152:119-121.
40. Bismark AW, Moreno FA, Stewart JL, Towers DN, Coan JA, Oas J, Erickson RP, Allen JJ. Polymorphisms of the HTR1a allele are linked to frontal brain electrical asymmetry. Biol Psychol 2010, 83:153-158. 10.1016/j.biopsycho.2009.12.002, 2845287, 20025927.
41. Enge S, Fleischhauer M, Lesch KP, Strobel A. On the role of serotonin and effort in voluntary attention: Evidence of genetic variation in N1 modulation. Behav Brain Res 2010,
42. Sysoeva OV, Maluchenko NV, Smirnov KS, Shleptsova VA, Ivanitsky AM, Tonevitsky AG. Peculiarities of brain information processing in persons with different serotonin transporter gene variants. Bull Exp Biol Med 2009, 148:731-734. 10.1007/s10517-010-0803-9, 20396779.
43. Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, Mergl R, Moller HJ, Hegerl U, Pogarell O. Prediction of treatment response in major depression: integration of concepts. J Affect Disord 2007, 98:215-225. 10.1016/j.jad.2006.07.021, 16996140.
44. Jelic V, Kowalski J. Evidence-based evaluation of diagnostic accuracy of resting EEG in dementia and mild cognitive impairment. Clin EEG Neurosci 2009, 40:129-142.
45. Neuper C, Grabner RH, Fink A, Neubauer AC. Long-term stability and consistency of EEG event-related (de-)synchronization across different cognitive tasks. Clin Neurophysiol 2005, 116:1681-1694. 10.1016/j.clinph.2005.03.013, 15922658.
46. Hermens DF, Soei EX, Clarke SD, Kohn MR, Gordon E, Williams LM. Resting EEG theta activity predicts cognitive performance in attention-deficit hyperactivity disorder. Pediatr Neurol 2005, 32:248-256. 10.1016/j.pediatrneurol.2004.11.009, 15797181.
47. Hoptman MJ, Davidson RJ. Baseline EEG asymmetries and performance on neuropsychological tasks. Neuropsychologia 1998, 36:1343-1353. 10.1016/S0028-3932(98)00023-2, 9863688.
48. Coben LA, Chi D, Snyder AZ, Storandt M. Replication of a study of frequency analysis of the resting awake EEG in mild probable Alzheimer's disease. Electroencephalogr Clin Neurophysiol 1990, 75:148-154. 10.1016/0013-4694(90)90168-J, 1689638.
49. Maluchenko NV, Schegolkova JV, Kulikova MA, Timofeeva MA, Shlepcova VA, Sysoeva OV, Tonevitsky AG. Gender effects on association of serotonin transporter gene polymorphism with symptoms of central fatigue. Bull Exp Biol Med 2009, 147:462-465. 10.1007/s10517-009-0559-2, 19704949.
50. Mizuno T, Aoki M, Shimada Y, Inoue M, Nakaya K, Takahashi T, Itoyama Y, Kanazawa M, Utsumi A, Endo Y, et al. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res 2006, 60:91-97. 10.1016/j.jpsychores.2005.06.068, 16380315.
51. Du L, Bakish D, Hrdina PD. Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet 2000, 10:159-164. 10.1097/00041444-200010040-00002, 11324940.
52. Duffy FH, Lyer G, Surwillo WW. Clinical electroencephalography and topographical brain mapping 1989, New York: Springer-Verlag.
53. Schneider S, Roessli D, Excoffier L. Arlequin ver 2.000: A software for population genetics data analysis. 2000, Genetics and Biometry Laboratory, University of Geneva, Switzerland.
54. van Belle G. Statistical Rules of Thumb 2002, New York: Wiley-Interscience, 1.
55. Kishida I, Aklillu E, Kawanishi C, Bertilsson L, Agren H. Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression. Neuropsychopharmacology 2007, 32:2143-2151. 10.1038/sj.npp.1301336, 17299512.
56. Haydon PG, McCobb DP, Kater SB. Serotonin selectively inhibits growth cone motility and synaptogenesis of specific identified neurons. Science 1984, 226:561-564. 10.1126/science.6093252, 6093252.
57. Whitaker-Azmitia PM, Azmitia EC. Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons. Brain Res 1989, 497:80-85. 10.1016/0006-8993(89)90972-4, 2790458.
58. Buznikov GA, Shmukler YB, Lauder JM. From oocyte to neuron: do neurotransmitters function in the same way throughout development?. Cell Mol Neurobiol 1996, 16:537-559.
59. Chubakov AR, Gromova EA, Konovalov GV, Chumasov EI, Sarkisova EF. Effect of serotonin on the development of a rat cerebral cortex tissue culture. Neurosci Behav Physiol 1986, 16:490-497. 10.1007/BF01191453, 3822085.
60. Djavadian RL. Serotonin and neurogenesis in the hippocampal dentate gyrus of adult mammals. Acta Neurobiol Exp (Wars) 2004, 64:189-200.
61. Jacobs BL. Adult brain neurogenesis and depression. Brain Behav Immun 2002, 16:602-609. 10.1016/S0889-1591(02)00015-6, 12401475.
62. Gould E. Serotonin and hippocampal neurogenesis. Neuropsychopharmacology 1999, 21:46S-51S.
63. Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet 2002, 114:347-353. 10.1002/ajmg.1700, 11920862.
64. Golimbet VE, Lebedeva IS, Alfimova MV, Korovaitseva GI, Lezheiko TV, Abramova LI, Kaleda VG. [Acoustic evoked potentials, serotonin transporter gene polymorphism and some psychopathological and psychological features in patients with schizophrenia and their relatives]. Zh Nevrol Psikhiatr Im S S Korsakova 2006, 106:44-49.
65. Strobel A, Debener S, Schmidt D, Hunnerkopf R, Lesch KP, Brocke B. Allelic variation in serotonin transporter function associated with the intensity dependence of the auditory evoked potential. Am J Med Genet B Neuropsychiatr Genet 2003, 118B:41-47. 10.1002/ajmg.b.10019, 12627465.
66. Hegerl U, Gallinat J, Juckel G. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?. J Affect Disord 2001, 62:93-100. 10.1016/S0165-0327(00)00353-0, 11172876.
67. Hegerl U, Juckel G. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials. World J Biol Psychiatry 2000, 1:112-118. 10.3109/15622970009150574, 12607207.
68. Asberg M. Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies. Ann N Y Acad Sci 1997, 836:158-181. 10.1111/j.1749-6632.1997.tb52359.x, 9616798.
69. Lin PY, Tsai G. Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004, 55:1023-1030. 10.1016/j.biopsych.2004.02.006, 15121487.
70. Knyazev GG, Savostyanov AN, Levin EA. Uncertainty, anxiety, and brain oscillations. Neurosci Lett 2005, 387:121-125. 10.1016/j.neulet.2005.06.016, 16002215.
71. Sviderskaia NE, Prudnikov VN, Antonov AG. Characteristics of EEG signs of anxiety in human. Zh Vyssh Nerv Deiat Im I P Pavlova 2001, 51:158-165.
72. Oathes DJ, Ray WJ, Yamasaki AS, Borkovec TD, Castonguay LG, Newman MG, Nitschke J. Worry, generalized anxiety disorder, and emotion: evidence from the EEG gamma band. Biol Psychol 2008, 79:165-170. 10.1016/j.biopsycho.2008.04.005, 2597009, 18499328.
73. Barry RJ, Rushby JA, Wallace MJ, Clarke AR, Johnstone SJ, Zlojutro I. Caffeine effects on resting-state arousal. Clin Neurophysiol 2005, 116:2693-2700. 10.1016/j.clinph.2005.08.008, 16221568.
74. Bonnet MH, Arand DL. Impact of activity and arousal upon spectral EEG parameters. Physiol Behav 2001, 74:291-298. 10.1016/S0031-9384(01)00581-9, 11714491.
75. Frodl T, Reinhold E, Koutsouleris N, Donohoe G, Bondy B, Reiser M, Moller HJ, Meisenzahl EM. Childhood stress, serotonin transporter gene and brain structures in major depression. Neuropsychopharmacology 2010, 35:1383-1390. 10.1038/npp.2010.8, 20147891.
76. Pacheco J, Beevers CG, Benavides C, McGeary J, Stice E, Schnyer DM. Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. J Neurosci 2009, 29:6229-6233. 10.1523/JNEUROSCI.0896-09.2009, 2720042, 19439600.
77. Hickie IB, Naismith SL, Ward PB, Scott EM, Mitchell PB, Schofield PR, Scimone A, Wilhelm K, Parker G. Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression. J Affect Disord 2007, 98:137-142. 10.1016/j.jad.2006.07.010, 16930719.
78. Summerfield C, Jack AI, Burgess AP. Induced gamma activity is associated with conscious awareness of pattern masked nouns. Int J Psychophysiol 2002, 44:93-100. 10.1016/S0167-8760(02)00003-X, 11909644.
79. Herrmann CS, Knight RT. Mechanisms of human attention: event-related potentials and oscillations. Neurosci Biobehav Rev 2001, 25:465-476. 10.1016/S0149-7634(01)00027-6, 11595268.
80. Varela F, Lachaux JP, Rodriguez E, Martinerie J. The brainweb: phase synchronization and large-scale integration. Nat Rev Neurosci 2001, 2:229-239.
81. Brovelli A, Lachaux JP, Kahane P, Boussaoud D. High gamma frequency oscillatory activity dissociates attention from intention in the human premotor cortex. Neuroimage 2005, 28:154-164. 10.1016/j.neuroimage.2005.05.045, 16023374.
82. Sambataro F, Murty VP, Callicott JH, Tan HY, Das S, Weinberger DR, Mattay VS. Age-related alterations in default mode network: impact on working memory performance. Neurobiol Aging 2010, 31:839-852. 10.1016/j.neurobiolaging.2008.05.022, 2842461, 18674847.
83. Charlton RA, Barrick TR, Lawes IN, Markus HS, Morris RG. White matter pathways associated with working memory in normal aging. Cortex 2010, 46:474-489. 10.1016/j.cortex.2009.07.005, 19666169.
84. Damoiseaux JS, Beckmann CF, Arigita EJ, Barkhof F, Scheltens P, Stam CJ, Smith SM, Rombouts SA. Reduced resting-state brain activity in the "default network" in normal aging. Cereb Cortex 2008, 18:1856-1864.
85. Golgeli A, Suer C, Ozesmi C, Dolu N, Ascioglu M, Sahin O. The effect of sex differences on event-related potentials in young adults. Int J Neurosci 1999, 99:69-77. 10.3109/00207459908994314, 10495197.
86. Kober SE, Neuper C. Sex differences in human EEG theta oscillations during spatial navigation in virtual reality. Int J Psychophysiol 2010,
87. Silas J, Levy JP, Nielsen MK, Slade L, Holmes A. Sex and individual differences in induced and evoked EEG measures of action observation. Neuropsychologia 2010, 48:2417-2426. 10.1016/j.neuropsychologia.2010.03.004, 20226800.
88. Latta F, Leproult R, Tasali E, Hofmann E, Van Cauter E. Sex differences in delta and alpha EEG activities in healthy older adults. Sleep 2005, 28:1525-1534.
89. Li J, Wang Y, Zhou R, Zhang H, Yang L, Wang B, Faraone SV. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:14-19. 10.1002/ajmg.b.30373, 16941663.
90. Yue W, Liu H, Zhang J, Zhang X, Wang X, Liu T, Liu P, Hao W. Association study of serotonin transporter gene polymorphisms with obstructive sleep apnea syndrome in Chinese Han population. Sleep 2008, 31:1535-1541. 2579982, 19014073.